The diameter-pressure characteristics of dorsal hand veins previously have not been characterized. In this study, the effects of distending pressure with and without infused norepinephrine on diameter and compliance were observed. The elevation needed for venous collapse was measured, and the effects of baseline constriction on venous reactivity were assessed. In seven supine subjects, a brachial cuff on an elevated arm was used to generate distending pressures while a linear variable displacement transformer (LVDT) measured changes in venous diameter. Arctangent functions of distending pressure were fitted to the normalized diameter, then compliance functions were calculated. In supine subjects, 5-15 cm of elevation emptied dorsal hand veins. Norepinephrine decreased the venous diameter at any distending pressure by increasing the P 50 without significantly changing the midpoint slope. Compliance was a nearly single-valued function of the normalized diameter with a maximum value at about 60% distention. Reactivity depends on distending pressure and baseline P 50 . Percentage constriction is a function of initial and final P 50 and of distending pressure.
Introduction
The venous circulation determines cardiac preload, yet its pressure-volume characteristics remain poorly characterized. The dorsal hand vein technique 1, 2 has been used extensively to measure venous compliance, but generally at only one distending pressure, despite the non-linear increase in venous diameter with distending pressure. Venoreactivity measurements, used to assess endothelial function, 3-7 also depend on the diameter pressure characteristics. We felt that an investigation of the diameter-pressure relationship of the dorsal hand vein was warranted.
The experimental diameter-pressure relationship for a vein is sigmoidal. One analytical expression that has been used to describe other sigmoidal curves is the arctangent relation. 8 Expressed in terms of diameter and pressure: D = D max ⋅ (0.5 + 1/ ⋅ arctan ((P − P 50 )/c)) where D max is the maximum diameter of the vessel, P is the distending (transmural) pressure, P 50 is the pressure associated with 50% distention, and c, the scaling factor on the pressure axis, determines the slope at the midpoint. The maximum diameter is an anatomical parameter for a given vein, while distending pressure, P 50 and the slope parameter (c) are functional parameters.
One of our goals was to characterize the diameter-pressure relationship under baseline conditions and to see how constriction affected it. This has not been done, although others have looked at the effects of pressure on the doseresponse to a constricting agent. 9 To investigate the diameter-pressure relationship in superficial hand veins under control conditions (saline infusion) and after infusion of norepinephrine we fitted the arctangent model to the data. It was hypothesized that norepinephrine would either shift the midpoint of the curve to higher distending pressures, increasing P 50 at constant slope, or change the midpoint slope or both. We compared the compliance-pressure relationship from the model to our data to assess dorsal hand vein compliance as a function of pressure and diameter. We also examined the effect of distending pressure and baseline distension on the interpretation of vascular reactivity.
Methods
We measured changes in dorsal hand vein diameter with increases in distending pressure using a linear variable differential transformer (LVDT) (MHR 025, Lucas Control System, Hampton, VA, USA). 2,10 An LVDT is a miniature transformer, the output voltage of which is proportional to the displacement of its mobile core. We calibrated the LVDT by placing it on a precision micrometer and reading the voltages corresponding to known displacements. The LVDT, mounted on a tiny tripod, was placed on the back of the subject's hand with the tripod legs clear of all surface veins and the lightweight core resting on the center point of the vein under study. During infusions we placed the LVDT core about 1 cm distal to the end of the needle. The tripod was fixed in place with a double-sided tape collar reinforced with bands of tape. We digitized, displayed and stored the output voltage on a computer.
It is critical for estimates of diameter that the arm be elevated sufficiently to collapse the vein when the cuff is deflated. In a preliminary study, we examined the hand height needed for venous collapse with no cuff inflation in different subject positions. No infusions were used. The xyphoid process was the height reference when subjects were seated or standing, and the mid-axillary line was the reference height when they were supine. We report measurements of dorsal hand veins in 19 young normal subjects seated and supine, and four subjects standing. The results were averaged across 3-5-cm elevations.
To characterize the diameter-pressure relationships we studied seven healthy subjects (six men, one woman) who had given written informed consent to participate in a drug reactivity study 11 approved by the Institutional Review Board of the Millard Fillmore Hospital. Subjects had a 23gauge butterfly needle inserted into a dorsal hand vein in a region free of branching points. Data are reported here for infusions of saline and of norepinephrine (50 ng/min in saline). The infusion rate was 0.2 ml/min.
The subjects lay supine in a quiet, partially darkened room with one arm elevated on a board slanted at 30 degrees to the horizontal. This elevated the hand about 15 cm above the right atrium, depending on the length of the forearm and the position of the base of the arm board. Subjects were covered in sufficient blankets to feel distinctly warm, and the arm was draped to the wrist to maintain skin temperature. We inflated a brachial cuff on the study arm in steps of 10 mmHg to 50 mmHg, the highest value that we felt would not restrict arterial inflow. Each pressure was held for at least 2 min, with additional time when needed until the vein diameter remained constant for 30 s as seen on the display.
LVDT numbers were converted to diameter by subtracting the reading when the vein was collapsed (no cuff inflation) and applying the calibration factor. Maximum diameters for each vein were found by fitting the arctangent model to individual diameter pressure curves for saline, using Marquardt's algorithm, a non-linear minimum mean square error parameter estimation method. We normalized the curves for each individual by dividing by that person's fitted saline D max , averaged across subjects, then used Marquardt's algorithm again to fit the arctangent model to the normalized saline and norepinephrine data. When several measurements were made at a single distending pressure within a subject, the average diameter for a pressure was computed to use in calculating the compliances.
Compliance is the change in lumen cross-sectional area with change in pressure:
where d is the differential operator. If the vessel is assumed to be circular, then
The change in diameter with pressure is simply the slope of the diameter-pressure curves. This is sometimes used without the diameter factor as an estimate of compliance.
The modeled (fitted) compliances for the normalized curves were calculated analytically from the fitted diameter-pressure curves. The slope of the arctangent diameterpressure relationship is: Slope = (c/) (1/(c 2 + (P−P 50 ) 2 )).
Because the function is sigmoidal, the slope is low at
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Experimental derivatives at any pressure were approximated from the normalized data using piecewise linear slopes. The slopes were computed using the differences of diameters for distending pressures bracketing a value. At distending pressure no value from a higher distending pressure was available. For the normalized saline curves the slopes were calculated from the diameter measured at 40 mmHg and an assumed value of unity (D max ) at 70 mmHg. For norepinephrine-constricted vessels at 50 mmHg distending pressure, the slope between values at 40 and 50 mmHg distending pressure was used.
Results
The results of the hand elevation study are presented in Figure 1 . The hand vein appears to be near minimum size at about 5-cm elevation in the supine subjects and at about 15-18-cm elevation in the seated and standing subjects. The approximately 15-cm elevation provided by the hand board for our supine subjects was sufficient to collapse the veins. In seated subjects, however, it might have been marginal.
Experimental diameter -pressure data from infusions of saline or 50 ng/min norepinephrine (NE) are shown in Figure 2 . The maximum diameters of the individual fitted curves ranged from 0.44 cm to 0.80 cm. The data were normalized to account for these anatomical inter-subject differences. The solid lines represent the arctangent relations fitted to the aggregate data.
The fitted curve for normalized saline infusion data accounted for 90% of the variability in the data (r = 0.95), while the fitted curve for normalized norepinephrine data accounted for 69% of the variability (r = 0.82). The fitted midpoint pressure (P 50 ) was 31 Ϯ 1 mmHg (mean Ϯ SE) for saline and 46 Ϯ 2 mmHg for norepinephrine (p Ͻ 0.01), while the midpoint slope parameter (c) was 8 Ϯ 1 mmHg for saline and 11 Ϯ 2 mmHg for norepinephrine (p Ͼ 0.2, not significantly different).
Diameter-pressure relations for individual subjects spanned a wide range. A distending pressure of 40 mmHg produced baseline dilations ranging from about 40% to 85% of maximum diameter. Further, the group of normalized diameters with saline alone overlapped the group with norepinephrine ( Figure 2) . P 50 for the individual, nonnormalized fitted curves for saline infusion data ranged from 23 mmHg to 37 mmHg.
Venous diameter at any distending pressure was smaller with norepinephrine than with saline alone. However, the relative effect of the norepinephrine on venous diameter was highly dependent on the distending pressure; comparing within subjects, the diameter during norepinephrine infusion averaged 74% of that with saline alone at 20 mmHg, 29% at 30 mmHg, 36% at 40 mmHg, and 46% at 50 mmHg. Similarly, the difference in slopes of the diameter pressure curves (Figure 2 ) and the difference in values of compliance (Figure 3a ) between the saline-and norepinephrine-treated veins were functions of distending pressure. According to the fitted curves, compliance reached its maximum values at 60% of D max in both treated and untreated veins (Figure 3b ). The maximum depends on the midpoint parameter c.
Discussion
Arctangent functions of pressure yielded good fits for dorsal hand vein diameter for both saline control and norepinephrine-exposed vessels. Arctangent (inverse tangent) curves are used frequently to describe the change in arterial cross-sectional area with pressure. 8 However, for our data the fit was better for measured diameter than for the area computed from it. We assumed that D max was a structural parameter unchanged by norepinephrine, an assumption we could not test because the venous pressure necessary to attain D max in constricted veins exceeded diastolic pressure. The arctangent diameter-pressure relationship presented here for a superficial vein was chosen because it described the data well. A Hill equation model also fit the data, though with a lower regression coefficient, and all of the arguments presented here can be based equally well on that model.
Baseline P 50 differed considerably in this data set. It is probable that the levels of endogenous norepinephrine were different among subjects. Norepinephrine release in the body is stimulated by many factors, both global and local. Among them are temperature (which we tried to control), emotional state, posture (supine here), absorptive state, and even local venous distention. Pre-existing venoconstriction may partially account for the occasional report of dilatory action to greater than 100% of the experimentally induced constriction. 7, 11 Drug-induced constriction or dilation of a vein, a common measure of venoreactivity, is usually expressed as a fraction of baseline diameter. It thus depends strongly on baseline constriction, as well as on sensitivity to drug, drug dose and distending pressure, as others also have shown. 9 The diameter at the selected distending pressure both limits the constriction possible and serves as the reference point for measures of per cent constriction. These points are illustrated in Figure 4 .
Two hypothetical veins have been represented by arctangent pressure-diameter curves in Figure 4a . One vein has a baseline P 50 of 25 mmHg ('lower baseline constriction') and the other a baseline P 50 of 35 mmHg ('higher baseline constriction'). At 30 mmHg distending pressure, the vein with lower baseline constriction has the possibility of constricting by 65% of its maximum diameter, while that with higher baseline constriction can lose only 35% of its maximum diameter. At 45 mmHg they are not as obviously different.
The technique of standardizing norepinephrine constriction to 80% at 45 mmHg distending pressure 3,10 is similar to increasing the P 50 to 70 mmHg, as shown. (The effect of different distending pressures is evident: at 30 mmHg, the veins with lower and higher baseline constrictions appear to be 88% and 78% constricted respectively - Figure 4b .) If an endothelially active agent added to reverse constriction lowers the P 50 to 50 mmHg in both veins, the reversal of constriction at 45 mmHg is about 20% for the vein with lower baseline constriction and about 45% for the vein with higher baseline constriction (Figure 4b ). This apparent disparity in effect occurs even though the constricted and partially relaxed curves are identical for the two different baselines.
Parameter fitting reduces the problem of interpretation caused by different baseline conditions. The information in Figure 4 can be expressed simply and unequivocally in terms of changes of P 50 . Parameters of fitted model curves before and after an intervention also provide a more concise description than that which has been published previously. 9 The entire range of the diameter-pressure relationship can be characterized by two parameters. For example, 50 ng/min of norepinephrine changed P 50 (shifted the pressure axis of the diameter-pressure relationship) by 15 mmHg without significantly changing the midpoint slope.
We propose characterizing drug sensitivity of hand veins in terms of the change in curve-fit parameters. This would necessitate constructing diameter pressure curves for control conditions and, at the minimum, locating the P 50 during drug exposure. We postulate that progressively increasing the dose of norepinephrine corresponds to progressively increasing the P 50 ; the model expression for constant distending pressure but increasing P 50 is a sigmoidal doseresponse curve starting at 1 and approaching 0, and steepest when the P 50 equals the distending pressure.
Unfortunately, the first description of LVDT use with dorsal hand veins 1 defined the ratio of the diameter to the distending pressure as compliance. In a curvilinear relationship, the ratio of diameter to distending pressure may be unrelated to either the slope or to the effect of incremental change. When a single dilating pressure is used, the value is just scaled diameter. An estimate of compliance, a sloperelated function, requires measurements of diameter and pressure at a minimum of two distending pressures no more than 10 mmHg apart. The cleanest estimate will be obtained from the derivative of a fitted diameter-pressure curve.
Compliance is defined here as change in cross-sectional area with change in pressure. Our data include pressures at which the compliance of the untreated veins is decreasing with increasing pressure but do not extend beyond the maximum compliance of the norepinephrine-constricted vessels. However, venous diameters are physically limited whether norepinephrine is present or not. The fitted curves indicate that a constricted vein is maximally compliant at a higher pressure (Figure 3a ) but at the same diameter (Figure 3b) as an unconstricted vein. The addition of norepinephrine at a constant distending pressure decreases the diameter of a vein, decreasing the compliance if the vein is initially 60% distended or less, but potentially increasing the compliance if the unconstricted vessel is more than 60% distended (Figures 2 and 3) . The maximum compliance in this series was slightly, though not statistically significantly, decreased by the addition of norepinephrine. However, the study was not powered to differentiate small changes in midpoint slope.
Compliant vessels are the flood-control reservoirs of the cardiovascular system. Not only do full reservoirs sequester large volumes, but they can provide no flood protection. Constricted veins that are smaller than maximum diameter can retain blood temporarily if the pressure increases suddenly, smoothing the cardiac preload, while veins that are fully distended must transmit any surges to the central ves-sels. It would be interesting to see if norepinephrine is released locally to keep the P 50 of a vein near the operating pressure, preserving the compliance function and reducing wall stress.
Compliance shown as a function of diameter (Figure 3b ) represents the effect of an isometric contraction. When the smooth muscle and elements in series with it are recruited by the addition of norepinephrine and the pressure is increased to restore the starting diameter, there may be a trend towards slight stiffening of the venous wall similar to that described by arterial wall models. 12 However, the diameter influenced venous stiffness more than did the presence or absence of the constrictor agent, suggesting that similar wall elements are stretched at a given diameter, whether or not smooth muscle is active.
While wall stress is higher in a norepinephrine-exposed vein, as compared with saline control at the same diameter because of the higher pressure, the stress is lower in the smaller, norepinephrine-treated vessel than in the larger saline control vein at the same pressure, according to Laplace's law.
Both pressure and diameter are reported in this study. We used cuff pressure as a surrogate for venous distending pressure. In a superficial vein, the transmural (distending) pressure is approximately equal to the intraluminal pressure because pressure outside is atmospheric. The steady state intraluminal pressure upstream of an inflated cuff will approximate the cuff pressure so long as cuff pressure is between arterial pressure and the venous pressure before cuff inflation. Superficial venous pressure without cuff inflation is approximately the central venous pressure (CVP) plus or minus the hydrostatic difference from the site to the great veins. (It is greater by the pressure drop of the flow between the measurement site and the central veins.)
When the measurement site is raised incrementally above the heart, the vein will remain distended until the height is great enough to compensate for any non-zero CVP. At greater elevations, the vein is in a 'waterfall' condition where transmural pressure is independent of downstream pressure. There, inflow pressure to the vein, that is, post capillary pressure minus the pressure drop in the venules, determines the distention. When inflow pressure is offset by height, the vein assumes a minimum diameter (Figure 1 ). Unless the inflow pressure changes, further elevation will not change the vein size.
Central venous pressure is normally close to atmospheric pressure in people who are seated or standing, and about 6 mmHg higher in supine subjects. Venous outflow pressures from the nailbeds of normal individuals have been reported to range from 8 cmH 2 O to 24.5 cmH 2 O, with a mean of 16.5 cmH 2 O, and those from hypertensive subjects range from 12.8 cmH 2 O to 58 cmH 2 O, with a mean of 30.8 cmH 2 O. 13 By conjecture, then, hypertensive subjects will require a greater limb elevation for venous collapse and will be at a different operating point on the non-linear diameter pressure curve for a given elevation. One could be misled to conclusions of compliance differences because measurements were made at different relative distensions but the same elevation.
Cuff inflation measurements on a stationary, elevated limb are cleaner and easier to perform than those based on hydrostatic pressure changes. The distending pressure is known with more certainty with a cuff than if hydrostatic Vascular Medicine 2001; 6: 97-102 effects are used because no estimates of CVP or of the vertical location of the right atrium need be made. Furthermore, the differences in skin traction, tendon position and muscle activation that can displace the diameter transducer are avoided. However, the limb must be sufficiently elevated to be at minimum diameter when the cuff is deflated. Supine studies are preferable to seated ones because less limb elevation is needed in supine subjects to attain the minimum venous diameter (Figure 1) . A measure of minimum diameter is needed both as the offset reading for LVDT measurements and as the origin of the diameterpressure curve.
The diameter of any blood vessel represents a balance of forces. Distending pressure is counteracted by elastic recoil of the distended wall and by active muscular contraction. Constrictor agents acutely affect the active, functional, muscular component, increasing the pressure needed to engage the structural elastic elements. Since the smooth muscle is less stiff than the other elements, the compliance is determined mostly by the passive structural elements. Compliance as a function of diameter gives structural information about a vein, indicating the stiffness of the materials stretched at each diameter. The pressure needed to reach a given diameter is a function of smooth muscle activation.
In conclusion, an arctangent function of pressure describes the non-linear venous diameter-pressure relation. Norepinephrine increases the midpoint pressure (P 50 ), perhaps without significantly changing the midpoint slope (c). The parametric curve description facilitates expression of compliance as a function of both distending pressure and diameter, topics not previously addressed for the hand vein. Compliance is nearly a single-valued function of venous distention, with a maximum at about 60% D max .
Where others have shown the effects of distending pressure on a norepinephrine dose-response curve, 9 we have examined the effects of norepinephrine on a diameterpressure curve. We believe that our results complement those of others, 9 allowing greater prediction of the interactions of distending pressure and drug dose. Model fitting and parameter comparison provides a clear description of drug effects on venous diameter-pressure relationships. This may be helpful in reconciling studies in which different distending pressures were used.
